<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02733042</url>
  </required_header>
  <id_info>
    <org_study_id>MEDI4736-NHL-001</org_study_id>
    <secondary_id>2015-003516-21</secondary_id>
    <nct_id>NCT02733042</nct_id>
  </id_info>
  <brief_title>A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia</brief_title>
  <acronym>FUSION NHL 001</acronym>
  <official_title>A Phase 1/2, Open-label, Multi-center Study to Assess the Safety and Tolerability of Durvalumab (Anti-PD-L1 Antibody) as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Celgene</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Celgene</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine the recommended phase 2 dose (RP2D), and the safety, and
      efficacy of durvalumab as monotherapy and when given in combination with lenalidomide and
      rituximab; ibrutinib; or bendamustine and rituximab at the RP2D in adults with lymphoma or
      chronic lymphocytic leukemia (CLL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was to consist of 3 parts: dose-finding, dose-confirmation, and dose-expansion. In
      this study, 4 treatment arms were to be investigated:

        -  Arm A: durvalumab and lenalidomide ± rituximab

        -  Arm B: durvalumab and ibrutinib

        -  Arm C: durvalumab and rituximab ± bendamustine

        -  Arm D: durvalumab (monotherapy)

      The study was to start with 3 dose-finding cohorts (Arms A, B, and C) and 1 dose-confirmation
      cohort (Arm D) in parallel. All treatment arms were to be open for enrollment at study start
      except in the US, where Arm D was to enroll depending on the availability of treatment slots
      and following the completion of assessment of responses from the combination therapy arms.
      For Arms A and C, prior to enrolling participants to receive all 3 drugs, the doublet
      combinations were to be evaluated. Once the doublet combinations were deemed tolerable, the
      eventual triplet combinations were to be tested.

      On 05 September 2017, the US FDA issued a Partial Clinical Hold on the study Arm A. Following
      this Partial Clinical Hold no more participants were enrolled into study Arm A. Participants
      already enrolled and treated in Arm A who were receiving clinical benefit, based on the
      discretion of the investigator, could continue study treatment after being reconsented. Arm B
      and C completed dose confirmation. The dose expansion part of the study was not opened.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 11, 2016</start_date>
  <completion_date type="Anticipated">July 8, 2022</completion_date>
  <primary_completion_date type="Actual">March 6, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Within Arms A, B, and C participants on the dose-finding part were enrolled sequentially according to a 3+3 design. All treatment arms were to be open for enrollment at study start except in the US, where Arm D was to enroll depending on the availability of treatment slots and following the completion of assessment of responses from the combination therapy arms.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Part 1: Number of Participants With Dose Limiting Toxicities (DLTs)</measure>
    <time_frame>Cycle 1 (28 days)</time_frame>
    <description>Dose limiting toxicities were evaluated during the DLT evaluation period for participants in the dose finding cohorts. The severity grading was determined according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version 4.03. A DLT is defined as below:
Hematologic DLT
Grade 4 neutropenia observed for greater than 5 days duration
Grade 3 neutropenia associated with fever (≥ 38.5 °C) of any duration
Grade 4 thrombocytopenia or Grade 3 thrombocytopenia with bleeding, or any requirement for platelets transfusion
Grade 4 anemia, unexplained by underlying disease
Any other grade 4 hematologic toxicity that does not resolve to participant's pretreatment baseline level within 72 hours.
Non-Hematologic DLT
Any non-hematological toxicity ≥ Grade 3 except for alopecia and nausea controlled by medical management
Any treatment interruption greater than 2 weeks due to adverse event.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Treatment-emergent Adverse Events</measure>
    <time_frame>From first dose of any study drug to 90 days after last dose of durvalumab or 28 days after last dose of other study drugs, up to the data cut-off date of 6 March 2019. Maximum time on treatment was 55.4 weeks for DUR and 130 weeks for other study drugs.</time_frame>
    <description>Treatment-emergent adverse events (TEAEs) are defined as adverse events (AEs) occurring or worsening on or after the first dose of any study treatment (durvalumab, lenalidomide, ibrutinib, bendamustine or rituximab) and within 90 days after last dose of durvalumab or 28 days after the last dose of other study drugs, whichever was later, as well as those serious adverse events made known to the investigator at any time thereafter that were suspected of being related to study treatment. The intensity of AEs was graded according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. For all other AEs not described in the CTCAE criteria, the intensity was assessed by the investigator as mild (Grade 1), moderate (Grade 2), severe (Grade 3), life-threatening (Grade 4), or death (Grade 5).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Response Rate (ORR) During Durvalumab Treatment</measure>
    <time_frame>Up to 13 cycles (12 months)</time_frame>
    <description>For lymphoma participants, response evaluation was based on International Working Group (IWG) response criteria for malignant lymphoma (the Lugano Classification). Overall response rate is defined as the percent of participants with best response of complete response (CR) or partial response (PR).
For chronic lymphocytic leukemia participants, response evaluation was based on International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for diagnosis and treatment of CLL. The ORR is defined as the percent of participants with best response of CR, complete response with incomplete marrow recovery (CRi), nodular partial response (nPR), PR, or partial response with lymphocytosis (PRL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Response Rate During the Entire Study</measure>
    <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
    <description>For lymphoma participants, response evaluation was based on International Working Group (IWG) response criteria for malignant lymphoma (the Lugano Classification) (Cheson, 2014). Overall response rate is defined as the percent of participants with best response of complete response (CR) or partial response (PR).
For chronic lymphocytic leukemia participants, response evaluation was based on International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for diagnosis and treatment of CLL. The ORR is defined as the percentage of participants with best response of CR, complete response with incomplete marrow recovery (CRi), nodular partial response (nPR), PR, or partial response with lymphocytosis (PRL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Response</measure>
    <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
    <description>Time to response was calculated as the time from first dose of study drug to the first response date (CR or PR for lymphoma participants and CR, CRi, nPR, PR, or PRL for CLL participants).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kaplan-Meier Estimate of Duration of Response</measure>
    <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
    <description>Duration of response is defined for responders only as the time from the first documented response (CR or PR for lymphoma participants or CR, CRi, nPR, PR, or PRL for CLL participants) to disease progression or death (from any cause). For participants with response but no progression, or death, duration of response was censored at the last date that the participant was known to be progression-free.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kaplan-Meier Estimate of Progression-free Survival (PFS)</measure>
    <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
    <description>Progression-free survival was calculated as the time from first dose of study drug to the first documented progression or death (from any cause) during the entire efficacy evaluation period. For participants with no progression or death, PFS was censored at the last assessment date the participant was known to be progression-free.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Observed Plasma Concentration (Cmax) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Maximum Plasma Concentration (Tmax) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-time Curve From Time Zero to Infinity (AUCinf) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Terminal Elimination Phase Half-Life (t½) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clearance (CL) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Distribution (Vz) of Durvalumab</measure>
    <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Observed Plasma Concentration (Cmax) of Lenalidomide</measure>
    <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Maximum Observed Plasma Concentration (Tmax) of Lenalidomide</measure>
    <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Lenalidomide</measure>
    <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Observed Plasma Concentration (Cmax) of Ibrutinib</measure>
    <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Maximum Observed Plasma Concentration (Tmax) of Ibrutinib</measure>
    <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Ibrutinib</measure>
    <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Soluble Programmed Cell Death Ligand-1 (sPD-L1) Concentration</measure>
    <time_frame>Baseline (Cycle 1 Day 1 predose) and Day 1 of Cycles 2 to 13</time_frame>
    <description>Change from baseline in sPD-L1 could not be calculated as all post-baseline samples were below the lower limit of quantification (&lt;15.60 pg/mL).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Lymphoma</condition>
  <condition>Leukemia, Lymphocytic, Chronic, B-Cell</condition>
  <arm_group>
    <arm_group_label>Arm A: Durvalumab + Lenalidomide ± Rituximab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to Arm A will receive:
Durvalumab 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and
Lenalidomide orally at assigned dose levels (10 mg, 15 mg or 20 mg) once daily on Days 1 to 21 of:
Cycles 1 through 13 in indolent non-Hodgkin's lymphoma (NHL) or
All cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL
Rituximab 375 mg/m² IV infusion every week in Cycle 1 (Days 2, 8, 15, 22) and on Day 1 of Cycles 2 through 5.
All treatment cycles were 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B: Durvalumab + Ibrutinib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to Arm B will receive:
Durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13
Ibrutinib orally at assigned dose levels (280 mg, 420 mg, or 560 mg) once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.
All treatment cycles were 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm C: Durvalumab + Rituximab ± Bendamustine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to Arm C will receive:
Durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13
Rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose will be 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose)
Bendamustine IV infusion at assigned dose levels (70 mg/m² or 90 mg/m²) on Days 1 and 2 of Cycles 1 through 6.
All treatment cycles were 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm D: Durvalumab Monotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to Arm D will receive durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13. All treatment cycles were 28 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Durvalumab</intervention_name>
    <description>Administered as an IV infusion (250 mL) over approximately 1 hour in duration</description>
    <arm_group_label>Arm A: Durvalumab + Lenalidomide ± Rituximab</arm_group_label>
    <arm_group_label>Arm B: Durvalumab + Ibrutinib</arm_group_label>
    <arm_group_label>Arm C: Durvalumab + Rituximab ± Bendamustine</arm_group_label>
    <arm_group_label>Arm D: Durvalumab Monotherapy</arm_group_label>
    <other_name>MEDI4736</other_name>
    <other_name>IMFINZI®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lenalidomide</intervention_name>
    <description>Administered orally</description>
    <arm_group_label>Arm A: Durvalumab + Lenalidomide ± Rituximab</arm_group_label>
    <other_name>Revlimid®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rituximab</intervention_name>
    <description>Administered by intravenous infusion</description>
    <arm_group_label>Arm A: Durvalumab + Lenalidomide ± Rituximab</arm_group_label>
    <arm_group_label>Arm C: Durvalumab + Rituximab ± Bendamustine</arm_group_label>
    <other_name>Rituxan®</other_name>
    <other_name>MabThera®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibrutinib</intervention_name>
    <description>Administered orally</description>
    <arm_group_label>Arm B: Durvalumab + Ibrutinib</arm_group_label>
    <other_name>Imbruvica®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bendamustine</intervention_name>
    <description>Administered as a 30-minute intravenous infusion</description>
    <arm_group_label>Arm C: Durvalumab + Rituximab ± Bendamustine</arm_group_label>
    <other_name>Treanda®</other_name>
    <other_name>Bendeka®</other_name>
    <other_name>Levact®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject who has histologically confirmed and documented B-cell lymphoma (eg,
             follicular, diffuse large B-cell, mantle cell, small lymphocytic, or Hodgkin lymphoma)
             and chronic lymphocytic leukemia.

          2. Subject who has high-risk chronic lymphocytic leukemia (CLL)/small lymphocytic
             lymphoma (SLL).

          3. Subject who was previously treated with at least one prior systemic chemotherapy,
             immunotherapy, or chemoimmunotherapy.

          4. Subject who has the Eastern Cooperative Oncology Group performance status of 0, 1, or
             2.

          5. Subject who is willing and able to undergo biopsy.

          6. Subject who has documented active relapsed or refractory disease requiring therapeutic
             intervention.

          7. Subject with lymphoma who has measurable disease (≥ 2.0 cm in its longest dimension by
             computed tomography) or chronic lymphocytic leukemia in need of treatment.

          8. Subject who fulfills the laboratory requirements as per protocol

        Exclusion Criteria

          1. Subject who has central nervous system (CNS) or meningeal involvement by lymphoma.

          2. Subject who has any histopathologic finding consistent with myelodysplastic syndrome
             on bone marrow studies.

          3. Subject who received any prior monoclonal antibodies against programmed cell death-1
             (PD-1) or programmed cell death ligand-1 (PD-L1) and/or any prior:

               1. Arm A only: drugs with immunomodulatory and other properties (eg, lenalidomide,
                  thalidomide);

               2. Arm B only: ibrutinib or other Bruton's tyrosine kinase (BTK) inhibitor;

               3. Arms C only: bendamustine

          4. Subject who has active auto-immune disease.

          5. Subject who has history of organ transplant or allogeneic hematopoietic stem cell
             transplantation.

          6. Subject who is seropositive for or active viral infection with hepatitis B virus (HBV)
             (hepatitis B surface antigen [HBsAg] positive and/or detectable viral DNA)

          7. Subject who has known seropositivity for or active infection for human
             immunodeficiency virus (HIV) or hepatitis C virus (HCV).

          8. Subject who has history of primary immunodeficiency or tuberculosis.

          9. Subject who other invasive malignancy within 2 years (5 years for Arm A) except for
             noninvasive malignancies such as cervical carcinoma in situ, non-melanomatous
             carcinoma of the skin, ductal carcinoma in situ of the breast, or incidental
             histologic finding of prostate cancer (T1a or T1b using the TNM [tumor, nodes,
             metastasis] clinical staging system) that has/have been surgically cured.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Delarue, MD</last_name>
    <role>Study Director</role>
    <affiliation>Celgene</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner MD Anderson Cancer Center</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Oncology Hematology</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Cancer Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shands Cancer Center University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Theurer Cancer Center at Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Peggy and Charles Stephenson Cancer Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jefferson Medical Oncology Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-4009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Avicennes</name>
      <address>
        <city>Bobigny Cedex</city>
        <zip>93009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Dijon Cedex</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille Cedex 9</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier Cedex 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Haut Leveque</name>
      <address>
        <city>Pessac Cedex</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Pierre-Benite CEDEX</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen Cedex</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UKG Universitatsklinikum Gottingen</name>
      <address>
        <city>GÃ¶ttingen</city>
        <zip>37099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum des Saarlandes</name>
      <address>
        <city>Homburg-Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinik Koln</name>
      <address>
        <city>KÃ¶ln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik III Klinikum der UniversitÃ¤t MÃ¼nchen-GroÃŸhadern</name>
      <address>
        <city>MÃ¼nchen</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spedali Civili Di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IEO- Istituto Europeo di Oncologia</name>
      <address>
        <city>Milano</city>
        <zip>20144</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. Ospedale Ca Granda - Niguarda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale</name>
      <address>
        <city>Napoli, Campania</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I.R.C.C.S. Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Humanitas Clinical Institute</name>
      <address>
        <city>Rozzano (milano)</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Chuo-ku</city>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokai University Hospital</name>
      <address>
        <city>Isehara City, Kanagawa</city>
        <zip>259-1193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aichi Cancer Center</name>
      <address>
        <city>Nagoya</city>
        <zip>464-8681</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU Academic Medical Center, Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMC Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leids Universitair Medisch Centrum</name>
      <address>
        <city>Leiden</city>
        <zip>2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St James University Hospital</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCL Cancer Institute</name>
      <address>
        <city>London</city>
        <zip>WC1E 6BT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christie Hospital NHS Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <zip>Ng5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine</name>
      <address>
        <city>Oxford</city>
        <zip>0X3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton University Hospitals NHS Trust</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 5, 2016</study_first_submitted>
  <study_first_submitted_qc>April 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2016</study_first_posted>
  <results_first_submitted>March 4, 2020</results_first_submitted>
  <results_first_submitted_qc>March 4, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 18, 2020</results_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lymphoma</keyword>
  <keyword>Chronic Lymphocytic Leukemia</keyword>
  <keyword>Durvalumab</keyword>
  <keyword>Anti-PD-L1 Antibody</keyword>
  <keyword>MEDI4736</keyword>
  <keyword>Immune Checkpoint</keyword>
  <keyword>Lymphatic Disease</keyword>
  <keyword>B-Cell Malignancies</keyword>
  <keyword>Abscopal Effect</keyword>
  <keyword>Lenalidomide</keyword>
  <keyword>Bendamustine</keyword>
  <keyword>Rituximab</keyword>
  <keyword>Ibrutinib</keyword>
  <keyword>Lymphoma, B-Cell</keyword>
  <keyword>Lymphoma, Non Hodgkin,</keyword>
  <keyword>Hodgkin Disease</keyword>
  <keyword>Leukemia, Lymphocytic, Chronic, B-Cell,</keyword>
  <keyword>Lymphoma, Follicular</keyword>
  <keyword>Lymphoma, Diffuse Large B-Cell</keyword>
  <keyword>Lymphoma, Mantle Cell</keyword>
  <keyword>Lymphoma, Small Lymphocytic</keyword>
  <keyword>Immune System Diseases</keyword>
  <keyword>Immunoproliferative Disorders</keyword>
  <keyword>Lymphoproliferative Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
    <mesh_term>Leukemia, Lymphocytic, Chronic, B-Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rituximab</mesh_term>
    <mesh_term>Durvalumab</mesh_term>
    <mesh_term>Lenalidomide</mesh_term>
    <mesh_term>Bendamustine Hydrochloride</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT02733042/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan: MEDI4736-NHL-001_SAP_Redacted.14Dec2017</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT02733042/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan: MEDI4736-NHL-001_SAP_Amendment_1_Redacted.14Dec2017</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT02733042/SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted at 32 sites in 6 countries: France, Italy, Japan, the Netherlands, the United Kingdom, and the US. The study was to consist of 3 parts: dose-finding (Part 1) dose-confirmation (Part 2), and dose-expansion (Part 3). Part 3 was not opened. The study is ongoing; results are based on a data cut-off date of March 6, 2019.</recruitment_details>
      <pre_assignment_details>Participants were assigned to 1 of 4 treatment arms based on the investigator's choice led by the participant's eligibility status per the inclusion/exclusion criteria for each treatment arm, prior antilymphoma/chronic lymphocytic leukemia (CLL) therapy, response to prior therapy, medical history, and the availability of open treatment slots.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
          <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
        </group>
        <group group_id="P2">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab (RIT) 375 mg/m² IV infusion on Days 2, 8, 15, and 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
        </group>
        <group group_id="P3">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
        </group>
        <group group_id="P4">
          <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib (IBR) 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="P5">
          <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="P6">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="P7">
          <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine (BEN) 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="P8">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="P9">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="P10">
          <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
          <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="P11">
          <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
          <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="P12">
          <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="P13">
          <title>Part 2 Arm C DLBCL: DUR mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="P14">
          <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="P15">
          <title>Part 2, Arm D FL: DUR 1500 mg</title>
          <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="P16">
          <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
          <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="P17">
          <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
          <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="P18">
          <title>Part 2, Arm D MCL: DUR 1500 mg</title>
          <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="P19">
          <title>Part 2 Arm D HL: DUR 1500 mg</title>
          <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Treatment Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="4"/>
                <participants group_id="P9" count="5"/>
                <participants group_id="P10" count="10"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="10"/>
                <participants group_id="P13" count="10"/>
                <participants group_id="P14" count="5"/>
                <participants group_id="P15" count="5"/>
                <participants group_id="P16" count="10"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="5"/>
                <participants group_id="P19" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="4"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="5"/>
                <participants group_id="P10" count="10"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="6"/>
                <participants group_id="P13" count="9"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="5"/>
                <participants group_id="P16" count="10"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="5"/>
                <participants group_id="P19" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="2"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progressive Disease</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="8"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="4"/>
                <participants group_id="P16" count="7"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Ongoing on Assigned Treatment</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="8"/>
                <participants group_id="P11" count="4"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Follow-up Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="4"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="5"/>
                <participants group_id="P12" count="9"/>
                <participants group_id="P13" count="9"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="5"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="4"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="5"/>
                <participants group_id="P12" count="9"/>
                <participants group_id="P13" count="9"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="5"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Ongoing on Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="4"/>
                <participants group_id="P12" count="9"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="8"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="4"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="1"/>
                <participants group_id="P19" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
          <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
        </group>
        <group group_id="B2">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
        </group>
        <group group_id="B3">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
        </group>
        <group group_id="B4">
          <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="B5">
          <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="B6">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="B7">
          <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="B8">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="B9">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/mÂ² + BEN 90 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="B10">
          <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mG</title>
          <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="B11">
          <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
          <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="B12">
          <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="B13">
          <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="B14">
          <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="B15">
          <title>Part 2, Arm D FL: DUR 1500 mg</title>
          <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="B16">
          <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
          <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="B17">
          <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
          <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="B18">
          <title>Part 2, Arm D MCL: DUR 1500 mg</title>
          <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="B19">
          <title>Part 2 Arm D HL: DUR 1500 mg</title>
          <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="B20">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="8"/>
            <count group_id="B4" value="3"/>
            <count group_id="B5" value="4"/>
            <count group_id="B6" value="3"/>
            <count group_id="B7" value="1"/>
            <count group_id="B8" value="4"/>
            <count group_id="B9" value="5"/>
            <count group_id="B10" value="10"/>
            <count group_id="B11" value="10"/>
            <count group_id="B12" value="10"/>
            <count group_id="B13" value="10"/>
            <count group_id="B14" value="5"/>
            <count group_id="B15" value="5"/>
            <count group_id="B16" value="10"/>
            <count group_id="B17" value="2"/>
            <count group_id="B18" value="5"/>
            <count group_id="B19" value="5"/>
            <count group_id="B20" value="106"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.0" lower_limit="50" upper_limit="78"/>
                    <measurement group_id="B2" value="66.0" lower_limit="52" upper_limit="75"/>
                    <measurement group_id="B3" value="77.0" lower_limit="53" upper_limit="80"/>
                    <measurement group_id="B4" value="58.0" lower_limit="54" upper_limit="74"/>
                    <measurement group_id="B5" value="68.0" lower_limit="57" upper_limit="81"/>
                    <measurement group_id="B6" value="79.0" lower_limit="76" upper_limit="80"/>
                    <measurement group_id="B7" value="70.0" lower_limit="70" upper_limit="70"/>
                    <measurement group_id="B8" value="68.0" lower_limit="52" upper_limit="78"/>
                    <measurement group_id="B9" value="38.0" lower_limit="21" upper_limit="77"/>
                    <measurement group_id="B10" value="68.0" lower_limit="55" upper_limit="73"/>
                    <measurement group_id="B11" value="73.5" lower_limit="54" upper_limit="84"/>
                    <measurement group_id="B12" value="64.5" lower_limit="45" upper_limit="75"/>
                    <measurement group_id="B13" value="60.0" lower_limit="46" upper_limit="71"/>
                    <measurement group_id="B14" value="68.0" lower_limit="53" upper_limit="79"/>
                    <measurement group_id="B15" value="52.0" lower_limit="39" upper_limit="71"/>
                    <measurement group_id="B16" value="61.5" lower_limit="22" upper_limit="76"/>
                    <measurement group_id="B17" value="62.0" lower_limit="55" upper_limit="69"/>
                    <measurement group_id="B18" value="77.0" lower_limit="69" upper_limit="80"/>
                    <measurement group_id="B19" value="51.0" lower_limit="34" upper_limit="65"/>
                    <measurement group_id="B20" value="67.0" lower_limit="21" upper_limit="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt; 65 Years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="4"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="5"/>
                    <measurement group_id="B13" value="7"/>
                    <measurement group_id="B14" value="2"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="5"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="4"/>
                    <measurement group_id="B20" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≥ 65 Years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="8"/>
                    <measurement group_id="B12" value="5"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="5"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="4"/>
                    <measurement group_id="B14" value="2"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="4"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="7"/>
                    <measurement group_id="B11" value="9"/>
                    <measurement group_id="B12" value="7"/>
                    <measurement group_id="B13" value="6"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="6"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="7"/>
                    <measurement group_id="B12" value="6"/>
                    <measurement group_id="B13" value="8"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="9"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="5"/>
                    <measurement group_id="B20" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="4"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="6"/>
                    <measurement group_id="B12" value="4"/>
                    <measurement group_id="B13" value="4"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="9"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="4"/>
                    <measurement group_id="B19" value="5"/>
                    <measurement group_id="B20" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Collected or Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="5"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="4"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Histology</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Follicular lymphoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="10"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="5"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Diffuse large B-cell lymphoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="5"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="10"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="10"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Marginal zone lymphoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Transformed follicular lymphoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mantle cell lymphoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="10"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="5"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>CLL / SLL</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="10"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="5"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hodgkin lymphoma</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="5"/>
                    <measurement group_id="B20" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Eastern Cooperative Oncology Group ECOG) Performance Status</title>
          <description>ECOG performance status is used to describe a patient’s level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). The scale ranges from 0 to 5:
0 = Fully active, no restrictions;
1 = Restricted activity but ambulatory, able to carry out work of a light nature;
2 = Ambulatory and capable of all self-care but unable to carry out work activities;
3 = Limited self-care, confined to bed or chair more than 50% of waking hours;
4 = Completely disabled, no selfcare, confined to bed or chair;
5 = Dead</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>0 - Fully Active</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="8"/>
                    <measurement group_id="B11" value="6"/>
                    <measurement group_id="B12" value="6"/>
                    <measurement group_id="B13" value="7"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="3"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="4"/>
                    <measurement group_id="B19" value="5"/>
                    <measurement group_id="B20" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 - Restricted but ambulatory</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="4"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 - Ambulatory but unable to work</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3 - Limited self-care</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Part 1: Number of Participants With Dose Limiting Toxicities (DLTs)</title>
        <description>Dose limiting toxicities were evaluated during the DLT evaluation period for participants in the dose finding cohorts. The severity grading was determined according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version 4.03. A DLT is defined as below:
Hematologic DLT
Grade 4 neutropenia observed for greater than 5 days duration
Grade 3 neutropenia associated with fever (≥ 38.5 °C) of any duration
Grade 4 thrombocytopenia or Grade 3 thrombocytopenia with bleeding, or any requirement for platelets transfusion
Grade 4 anemia, unexplained by underlying disease
Any other grade 4 hematologic toxicity that does not resolve to participant's pretreatment baseline level within 72 hours.
Non-Hematologic DLT
Any non-hematological toxicity ≥ Grade 3 except for alopecia and nausea controlled by medical management
Any treatment interruption greater than 2 weeks due to adverse event.</description>
        <time_frame>Cycle 1 (28 days)</time_frame>
        <population>DLT Evaluable population included participants in Arms A, B, and C of Part 1, who took at least one dose of study drug and completed the DLT evaluation through the end of DLT evaluation period, or participants who took at least one dose of study drug and experienced at least one DLT prior to completion of the DLT evaluation period.</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Part 1: Number of Participants With Dose Limiting Toxicities (DLTs)</title>
          <description>Dose limiting toxicities were evaluated during the DLT evaluation period for participants in the dose finding cohorts. The severity grading was determined according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version 4.03. A DLT is defined as below:
Hematologic DLT
Grade 4 neutropenia observed for greater than 5 days duration
Grade 3 neutropenia associated with fever (≥ 38.5 °C) of any duration
Grade 4 thrombocytopenia or Grade 3 thrombocytopenia with bleeding, or any requirement for platelets transfusion
Grade 4 anemia, unexplained by underlying disease
Any other grade 4 hematologic toxicity that does not resolve to participant's pretreatment baseline level within 72 hours.
Non-Hematologic DLT
Any non-hematological toxicity ≥ Grade 3 except for alopecia and nausea controlled by medical management
Any treatment interruption greater than 2 weeks due to adverse event.</description>
          <population>DLT Evaluable population included participants in Arms A, B, and C of Part 1, who took at least one dose of study drug and completed the DLT evaluation through the end of DLT evaluation period, or participants who took at least one dose of study drug and experienced at least one DLT prior to completion of the DLT evaluation period.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="6"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="4"/>
                <count group_id="O9" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>The safety review committee identified a preliminary recommended Phase 2 dose (RP2D) for each dose finding cohort based on an integrated assessment of the safety, pharmacokinetic, pharmacodynamic, and preliminary efficacy (as available).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <other_analysis_desc>For Arm B, ibrutinib 420 mg was confirmed as the RP2D for CLL/SLL participants and ibrutinib 560 mg was confirmed as the RP2D for MCL participants.</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
              <group_id>O9</group_id>
            </group_id_list>
            <groups_desc>The safety review committee identified a preliminary recommended Phase 2 dose (RP2D) for each dose finding cohort based on an integrated assessment of the safety, pharmacokinetic, pharmacodynamic, and preliminary efficacy (as available).</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <other_analysis_desc>For Arm C the RP2D was confirmed as rituximab 375 mg/m² + bendamustine 70 mg/m².</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Treatment-emergent Adverse Events</title>
        <description>Treatment-emergent adverse events (TEAEs) are defined as adverse events (AEs) occurring or worsening on or after the first dose of any study treatment (durvalumab, lenalidomide, ibrutinib, bendamustine or rituximab) and within 90 days after last dose of durvalumab or 28 days after the last dose of other study drugs, whichever was later, as well as those serious adverse events made known to the investigator at any time thereafter that were suspected of being related to study treatment. The intensity of AEs was graded according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. For all other AEs not described in the CTCAE criteria, the intensity was assessed by the investigator as mild (Grade 1), moderate (Grade 2), severe (Grade 3), life-threatening (Grade 4), or death (Grade 5).</description>
        <time_frame>From first dose of any study drug to 90 days after last dose of durvalumab or 28 days after last dose of other study drugs, up to the data cut-off date of 6 March 2019. Maximum time on treatment was 55.4 weeks for DUR and 130 weeks for other study drugs.</time_frame>
        <population>The Safety population included all participants who received at least 1 dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Treatment-emergent Adverse Events</title>
          <description>Treatment-emergent adverse events (TEAEs) are defined as adverse events (AEs) occurring or worsening on or after the first dose of any study treatment (durvalumab, lenalidomide, ibrutinib, bendamustine or rituximab) and within 90 days after last dose of durvalumab or 28 days after the last dose of other study drugs, whichever was later, as well as those serious adverse events made known to the investigator at any time thereafter that were suspected of being related to study treatment. The intensity of AEs was graded according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. For all other AEs not described in the CTCAE criteria, the intensity was assessed by the investigator as mild (Grade 1), moderate (Grade 2), severe (Grade 3), life-threatening (Grade 4), or death (Grade 5).</description>
          <population>The Safety population included all participants who received at least 1 dose of study drug.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="4"/>
                <count group_id="O9" value="5"/>
                <count group_id="O10" value="10"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="10"/>
                <count group_id="O13" value="10"/>
                <count group_id="O14" value="5"/>
                <count group_id="O15" value="5"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="2"/>
                <count group_id="O18" value="5"/>
                <count group_id="O19" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="10"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="10"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="5"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TEAE Related to Any Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="10"/>
                    <measurement group_id="O11" value="9"/>
                    <measurement group_id="O12" value="10"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="3"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CTCAE Grade 3-4 TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="10"/>
                    <measurement group_id="O12" value="6"/>
                    <measurement group_id="O13" value="9"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="4"/>
                    <measurement group_id="O19" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CTCAE Grade 3-4 TEAE Related to Any Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="7"/>
                    <measurement group_id="O11" value="6"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="7"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CTCAE Grade 5 TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CTCAE Grade 5 TEAE Related to Any Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="7"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious TEAE Related to Any Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TEAE Leading to Discontinuation of Any Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TEAE Leading to Dose Modifications of Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="8"/>
                    <measurement group_id="O11" value="9"/>
                    <measurement group_id="O12" value="7"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Response Rate (ORR) During Durvalumab Treatment</title>
        <description>For lymphoma participants, response evaluation was based on International Working Group (IWG) response criteria for malignant lymphoma (the Lugano Classification). Overall response rate is defined as the percent of participants with best response of complete response (CR) or partial response (PR).
For chronic lymphocytic leukemia participants, response evaluation was based on International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for diagnosis and treatment of CLL. The ORR is defined as the percent of participants with best response of CR, complete response with incomplete marrow recovery (CRi), nodular partial response (nPR), PR, or partial response with lymphocytosis (PRL).</description>
        <time_frame>Up to 13 cycles (12 months)</time_frame>
        <population>The Efficacy Evaluable population includes all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Response Rate (ORR) During Durvalumab Treatment</title>
          <description>For lymphoma participants, response evaluation was based on International Working Group (IWG) response criteria for malignant lymphoma (the Lugano Classification). Overall response rate is defined as the percent of participants with best response of complete response (CR) or partial response (PR).
For chronic lymphocytic leukemia participants, response evaluation was based on International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for diagnosis and treatment of CLL. The ORR is defined as the percent of participants with best response of CR, complete response with incomplete marrow recovery (CRi), nodular partial response (nPR), PR, or partial response with lymphocytosis (PRL).</description>
          <population>The Efficacy Evaluable population includes all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="4"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="10"/>
                <count group_id="O14" value="4"/>
                <count group_id="O15" value="5"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="2"/>
                <count group_id="O18" value="5"/>
                <count group_id="O19" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="0.8" upper_limit="90.6"/>
                    <measurement group_id="O2" value="66.7" lower_limit="9.4" upper_limit="99.2"/>
                    <measurement group_id="O3" value="80.0" lower_limit="28.4" upper_limit="99.5"/>
                    <measurement group_id="O4" value="66.7" lower_limit="9.4" upper_limit="99.2"/>
                    <measurement group_id="O5" value="75.0" lower_limit="19.4" upper_limit="99.4"/>
                    <measurement group_id="O6" value="33.3" lower_limit="0.8" upper_limit="90.6"/>
                    <measurement group_id="O8" value="50.0" lower_limit="6.8" upper_limit="93.2"/>
                    <measurement group_id="O9" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O10" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O11" value="60.0" lower_limit="26.2" upper_limit="87.8"/>
                    <measurement group_id="O12" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O13" value="30.0" lower_limit="6.7" upper_limit="65.2"/>
                    <measurement group_id="O14" value="50.0" lower_limit="6.8" upper_limit="93.2"/>
                    <measurement group_id="O15" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O16" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O17" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O18" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O19" value="20.0" lower_limit="0.5" upper_limit="71.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Response Rate During the Entire Study</title>
        <description>For lymphoma participants, response evaluation was based on International Working Group (IWG) response criteria for malignant lymphoma (the Lugano Classification) (Cheson, 2014). Overall response rate is defined as the percent of participants with best response of complete response (CR) or partial response (PR).
For chronic lymphocytic leukemia participants, response evaluation was based on International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for diagnosis and treatment of CLL. The ORR is defined as the percentage of participants with best response of CR, complete response with incomplete marrow recovery (CRi), nodular partial response (nPR), PR, or partial response with lymphocytosis (PRL).</description>
        <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
        <population>The Efficacy Evaluable population includes all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Response Rate During the Entire Study</title>
          <description>For lymphoma participants, response evaluation was based on International Working Group (IWG) response criteria for malignant lymphoma (the Lugano Classification) (Cheson, 2014). Overall response rate is defined as the percent of participants with best response of complete response (CR) or partial response (PR).
For chronic lymphocytic leukemia participants, response evaluation was based on International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for diagnosis and treatment of CLL. The ORR is defined as the percentage of participants with best response of CR, complete response with incomplete marrow recovery (CRi), nodular partial response (nPR), PR, or partial response with lymphocytosis (PRL).</description>
          <population>The Efficacy Evaluable population includes all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="5"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="4"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="9"/>
                <count group_id="O13" value="10"/>
                <count group_id="O14" value="4"/>
                <count group_id="O15" value="5"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="2"/>
                <count group_id="O18" value="5"/>
                <count group_id="O19" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="9.4" upper_limit="99.2"/>
                    <measurement group_id="O2" value="66.7" lower_limit="9.4" upper_limit="99.2"/>
                    <measurement group_id="O3" value="80.0" lower_limit="28.4" upper_limit="99.5"/>
                    <measurement group_id="O4" value="66.7" lower_limit="9.4" upper_limit="99.2"/>
                    <measurement group_id="O5" value="75.0" lower_limit="19.4" upper_limit="99.4"/>
                    <measurement group_id="O6" value="33.3" lower_limit="0.8" upper_limit="90.6"/>
                    <measurement group_id="O8" value="50.0" lower_limit="6.8" upper_limit="93.2"/>
                    <measurement group_id="O9" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O10" value="100.0" lower_limit="66.4" upper_limit="100.0"/>
                    <measurement group_id="O11" value="70.0" lower_limit="34.8" upper_limit="93.3"/>
                    <measurement group_id="O12" value="88.9" lower_limit="51.8" upper_limit="99.7"/>
                    <measurement group_id="O13" value="30.0" lower_limit="6.7" upper_limit="65.2"/>
                    <measurement group_id="O14" value="50.0" lower_limit="6.8" upper_limit="93.2"/>
                    <measurement group_id="O15" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O16" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O17" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O18" value="0" lower_limit="NA" upper_limit="NA">Not calculated for zero responses</measurement>
                    <measurement group_id="O19" value="20.0" lower_limit="0.5" upper_limit="71.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Response</title>
        <description>Time to response was calculated as the time from first dose of study drug to the first response date (CR or PR for lymphoma participants and CR, CRi, nPR, PR, or PRL for CLL participants).</description>
        <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
        <population>Efficacy evaluable population (all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment) who had an objective response</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Response</title>
          <description>Time to response was calculated as the time from first dose of study drug to the first response date (CR or PR for lymphoma participants and CR, CRi, nPR, PR, or PRL for CLL participants).</description>
          <population>Efficacy evaluable population (all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment) who had an objective response</population>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="7"/>
                <count group_id="O12" value="8"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="2"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.85" lower_limit="12.1" upper_limit="129.6"/>
                    <measurement group_id="O2" value="12.60" lower_limit="12.1" upper_limit="13.1"/>
                    <measurement group_id="O3" value="18.20" lower_limit="11.3" upper_limit="36.1"/>
                    <measurement group_id="O4" value="11.85" lower_limit="11.4" upper_limit="12.3"/>
                    <measurement group_id="O5" value="13.40" lower_limit="12.4" upper_limit="52.9"/>
                    <measurement group_id="O6" value="13.00" lower_limit="13.0" upper_limit="13.0"/>
                    <measurement group_id="O8" value="13.10" lower_limit="12.1" upper_limit="14.1"/>
                    <measurement group_id="O10" value="12.10" lower_limit="10.9" upper_limit="72.9"/>
                    <measurement group_id="O11" value="12.10" lower_limit="6.6" upper_limit="26.4"/>
                    <measurement group_id="O12" value="12.35" lower_limit="10.3" upper_limit="15.3"/>
                    <measurement group_id="O13" value="12.00" lower_limit="8.7" upper_limit="12.1"/>
                    <measurement group_id="O14" value="12.10" lower_limit="12.1" upper_limit="12.1"/>
                    <measurement group_id="O19" value="13.10" lower_limit="13.1" upper_limit="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Kaplan-Meier Estimate of Duration of Response</title>
        <description>Duration of response is defined for responders only as the time from the first documented response (CR or PR for lymphoma participants or CR, CRi, nPR, PR, or PRL for CLL participants) to disease progression or death (from any cause). For participants with response but no progression, or death, duration of response was censored at the last date that the participant was known to be progression-free.</description>
        <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
        <population>Efficacy evaluable population (all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment) who had an objective response</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Kaplan-Meier Estimate of Duration of Response</title>
          <description>Duration of response is defined for responders only as the time from the first documented response (CR or PR for lymphoma participants or CR, CRi, nPR, PR, or PRL for CLL participants) to disease progression or death (from any cause). For participants with response but no progression, or death, duration of response was censored at the last date that the participant was known to be progression-free.</description>
          <population>Efficacy evaluable population (all participants who completed at least 1 cycle of their assigned treatment, and have baseline and at least 1 post-baseline tumor response assessment) who had an objective response</population>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="7"/>
                <count group_id="O12" value="8"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="2"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.14" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O3" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O4" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O5" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O6" value="29.29" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O8" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O10" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O11" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O12" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O13" value="24.14" lower_limit="9.14" upper_limit="26.14"/>
                    <measurement group_id="O14" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O19" value="11.14" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Kaplan-Meier Estimate of Progression-free Survival (PFS)</title>
        <description>Progression-free survival was calculated as the time from first dose of study drug to the first documented progression or death (from any cause) during the entire efficacy evaluation period. For participants with no progression or death, PFS was censored at the last assessment date the participant was known to be progression-free.</description>
        <time_frame>From first dose of any study drug to the end of follow-up, up to the data cutoff date of March 6, 2019; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
        <population>Safety population</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Kaplan-Meier Estimate of Progression-free Survival (PFS)</title>
          <description>Progression-free survival was calculated as the time from first dose of study drug to the first documented progression or death (from any cause) during the entire efficacy evaluation period. For participants with no progression or death, PFS was censored at the last assessment date the participant was known to be progression-free.</description>
          <population>Safety population</population>
          <units>months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="4"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="4"/>
                <count group_id="O9" value="5"/>
                <count group_id="O10" value="10"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="10"/>
                <count group_id="O13" value="10"/>
                <count group_id="O14" value="5"/>
                <count group_id="O15" value="5"/>
                <count group_id="O16" value="10"/>
                <count group_id="O17" value="2"/>
                <count group_id="O18" value="5"/>
                <count group_id="O19" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.41" lower_limit="5.09" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O3" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O4" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O5" value="28.71" lower_limit="4.50" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O6" value="9.69" lower_limit="1.64" upper_limit="12.68"/>
                    <measurement group_id="O7" value="1.25" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O8" value="3.82" lower_limit="1.25" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O9" value="2.48" lower_limit="0.49" upper_limit="5.91"/>
                    <measurement group_id="O10" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O11" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O12" value="14.65" lower_limit="5.75" upper_limit="14.65"/>
                    <measurement group_id="O13" value="2.06" lower_limit="0.76" upper_limit="8.28"/>
                    <measurement group_id="O14" value="NA" lower_limit="NA" upper_limit="NA">Could not be evaluated due to the low number of events</measurement>
                    <measurement group_id="O15" value="1.68" lower_limit="0.69" upper_limit="4.63"/>
                    <measurement group_id="O16" value="1.17" lower_limit="0.26" upper_limit="3.19"/>
                    <measurement group_id="O17" value="2.76" lower_limit="2.50" upper_limit="3.02"/>
                    <measurement group_id="O18" value="2.33" lower_limit="0.79" upper_limit="10.02"/>
                    <measurement group_id="O19" value="2.66" lower_limit="2.56" upper_limit="5.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Observed Plasma Concentration (Cmax) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>The Pharmacokinetic (PK) population included all participants who received at least 1 dose of study drug and had at least 1 measurable plasma concentration.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide ± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Observed Plasma Concentration (Cmax) of Durvalumab</title>
          <population>The Pharmacokinetic (PK) population included all participants who received at least 1 dose of study drug and had at least 1 measurable plasma concentration.</population>
          <units>μg/L</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420264.066" spread="22.7"/>
                    <measurement group_id="O2" value="361906.229" spread="30.1"/>
                    <measurement group_id="O3" value="331572.478" spread="33.4"/>
                    <measurement group_id="O4" value="392663.668" spread="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Maximum Plasma Concentration (Tmax) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>PK population</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide ± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Maximum Plasma Concentration (Tmax) of Durvalumab</title>
          <population>PK population</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0510" lower_limit="0.042" upper_limit="1.035"/>
                    <measurement group_id="O2" value="0.0479" lower_limit="0.041" upper_limit="1.061"/>
                    <measurement group_id="O3" value="0.0510" lower_limit="0.042" upper_limit="6.788"/>
                    <measurement group_id="O4" value="0.0420" lower_limit="0.038" upper_limit="1.986"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>The PK population</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide ± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Durvalumab</title>
          <population>The PK population</population>
          <units>days*μg/L</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3120149.759" spread="29.5"/>
                    <measurement group_id="O2" value="3225869.344" spread="31.9"/>
                    <measurement group_id="O3" value="2670168.397" spread="46.7"/>
                    <measurement group_id="O4" value="3053060.746" spread="37.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Plasma Concentration-time Curve From Time Zero to Infinity (AUCinf) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>The PK population</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide ± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Plasma Concentration-time Curve From Time Zero to Infinity (AUCinf) of Durvalumab</title>
          <population>The PK population</population>
          <units>days*μg/L</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4867431.378" spread="23.3"/>
                    <measurement group_id="O2" value="5818262.846" spread="42.1"/>
                    <measurement group_id="O3" value="4762968.345" spread="71.0"/>
                    <measurement group_id="O4" value="5593532.553" spread="53.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Terminal Elimination Phase Half-Life (t½) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>The PK population</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide Â± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Terminal Elimination Phase Half-Life (t½) of Durvalumab</title>
          <population>The PK population</population>
          <units>days</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.596" spread="46.6"/>
                    <measurement group_id="O2" value="17.344" spread="47.3"/>
                    <measurement group_id="O3" value="16.327" spread="57.4"/>
                    <measurement group_id="O4" value="15.399" spread="53.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clearance (CL) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>The PK population</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide ± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Clearance (CL) of Durvalumab</title>
          <population>The PK population</population>
          <units>L/day</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3082" spread="23.3"/>
                    <measurement group_id="O2" value="0.2578" spread="42.1"/>
                    <measurement group_id="O3" value="0.3149" spread="71.0"/>
                    <measurement group_id="O4" value="0.2682" spread="53.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume of Distribution (Vz) of Durvalumab</title>
        <time_frame>Cycle 1, Day 1 (pre-dose and at end of infusion), and 4, 24, 48, 168 (Day 8), 336 (Day 15), and 508 (Day 22) hours after the end of infusion.</time_frame>
        <population>The PK population</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Durvalumab + Lenalidomide ± Rituximab</title>
            <description>Participants assigned to Arm A received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 10 mg or 20 mg lenalidomide orally once daily on Days 1 to 21 of Cycles 1 to 13 in indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in aggressive NHL, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Durvalumab + Ibrutinib</title>
            <description>Participants assigned to Arm B received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and 420 or 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O3">
            <title>Arm C: Durvalumab + Bendamustine ± Rituximab</title>
            <description>Participants assigned to Arm C received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, 70 or 90 mg/m² bendamustine IV on Days 1 and 2 of Cycles 1 to 6, and rituximab 375 mg/m² IV on Day 2 of Cycles 1 to 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O4">
            <title>Arm D: Durvalumab Monotherapy</title>
            <description>Participants assigned to Arm D received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Volume of Distribution (Vz) of Durvalumab</title>
          <population>The PK population</population>
          <units>liters</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.155" spread="41.9"/>
                    <measurement group_id="O2" value="6.451" spread="38.3"/>
                    <measurement group_id="O3" value="7.418" spread="33.7"/>
                    <measurement group_id="O4" value="5.957" spread="33.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Observed Plasma Concentration (Cmax) of Lenalidomide</title>
        <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
        <population>PK population with available data at each time point</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Lenalidomide 10 mg</title>
            <description>Participants in Arm A received lenalidomide 10 mg orally once daily on Days 1 to 21 of Cycles 1 to 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm A: Lenalidomide 20 mg</title>
            <description>Participants in Arm A received lenalidomide 20 mg orally once daily on Days 1 to 21 of Cycles 1 to 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Observed Plasma Concentration (Cmax) of Lenalidomide</title>
          <population>PK population with available data at each time point</population>
          <units>ng/mL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141.881" spread="22.0"/>
                    <measurement group_id="O2" value="309.917" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.635" spread="40.9"/>
                    <measurement group_id="O2" value="174.090"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Maximum Observed Plasma Concentration (Tmax) of Lenalidomide</title>
        <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
        <population>PK population with available data at each time point</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Lenalidomide 10 mg</title>
            <description>Participants in Arm A received lenalidomide 10 mg orally once daily on Days 1 to 21 of Cycles 1 to 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm A: Lenalidomide 20 mg</title>
            <description>Participants in Arm A received lenalidomide 20 mg orally once daily on Days 1 to 21 of Cycles 1 to 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Maximum Observed Plasma Concentration (Tmax) of Lenalidomide</title>
          <population>PK population with available data at each time point</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9500" lower_limit="1.000" upper_limit="3.917"/>
                    <measurement group_id="O2" value="1.1667" lower_limit="1.000" upper_limit="1.433"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0333" lower_limit="1.233" upper_limit="4.000"/>
                    <measurement group_id="O2" value="1.000" lower_limit="1.000" upper_limit="1.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Lenalidomide</title>
        <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose</time_frame>
        <population>PK population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Lenalidomide 10 mg</title>
            <description>Participants in Arm A received lenalidomide 10 mg orally once daily on Days 1 to 21 of Cycles 1 to 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
          <group group_id="O2">
            <title>Arm A: Lenalidomide 20 mg</title>
            <description>Participants in Arm A received lenalidomide 20 mg orally once daily on Days 1 to 21 of Cycles 1 to 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 to 13, and rituximab 375 mg/m² IV weekly in Cycle 1 and on Day 1 of Cycles 2 to 5.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Lenalidomide</title>
          <population>PK population with available data</population>
          <units>h*ng/mL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="789.297" spread="84.3"/>
                    <measurement group_id="O2" value="805.299" spread="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Observed Plasma Concentration (Cmax) of Ibrutinib</title>
        <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
        <population>PK population with available data at each time point</population>
        <group_list>
          <group group_id="O1">
            <title>Arm B: Ibrutinib 420 mg</title>
            <description>Participants assigned to Arm B received 420 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason, and durvalumab 1500 mg IV on Day 1 of Cycles 1 to 13.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Ibrutinib 560 mg</title>
            <description>Participants assigned to Arm B received 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason, and durvalumab 1500 mg IV on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Observed Plasma Concentration (Cmax) of Ibrutinib</title>
          <population>PK population with available data at each time point</population>
          <units>ng/mL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.704" spread="98.0"/>
                    <measurement group_id="O2" value="67.728" spread="197.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.840" spread="136.9"/>
                    <measurement group_id="O2" value="72.436" spread="166.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Maximum Observed Plasma Concentration (Tmax) of Ibrutinib</title>
        <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose, and Cycle 1 Day 15 at pre-dose, 1, 2, and 4 hours post-dose.</time_frame>
        <population>PK population with available data at each time point</population>
        <group_list>
          <group group_id="O1">
            <title>Arm B: Ibrutinib 420 mg</title>
            <description>Participants assigned to Arm B received 420 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason, and durvalumab 1500 mg IV on Day 1 of Cycles 1 to 13.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Ibrutinib 560 mg</title>
            <description>Participants assigned to Arm B received 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason, and durvalumab 1500 mg IV on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Maximum Observed Plasma Concentration (Tmax) of Ibrutinib</title>
          <population>PK population with available data at each time point</population>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.000" lower_limit="0.000" upper_limit="4.367"/>
                    <measurement group_id="O2" value="1.9333" lower_limit="0.933" upper_limit="3.917"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="9"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8833" lower_limit="1.000" upper_limit="4.000"/>
                    <measurement group_id="O2" value="2.000" lower_limit="1.000" upper_limit="4.083"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Ibrutinib</title>
        <time_frame>Cycle 1 Day 1 at predose and 1, 2, 4, and 24 hours post-dose</time_frame>
        <population>PK population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Arm B: Ibrutinib 420 mg</title>
            <description>Participants assigned to Arm B received 420 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason, and durvalumab 1500 mg IV on Day 1 of Cycles 1 to 13.</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Ibrutinib 560 mg</title>
            <description>Participants assigned to Arm B received 560 mg ibrutinib orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason, and durvalumab 1500 mg IV on Day 1 of Cycles 1 to 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Plasma Concentration-time Curve From Time Zero to the Last Measurable Concentration (AUClast) of Ibrutinib</title>
          <population>PK population with available data</population>
          <units>h*ng/mL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="586.396" spread="117.2"/>
                    <measurement group_id="O2" value="436.855" spread="246.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Soluble Programmed Cell Death Ligand-1 (sPD-L1) Concentration</title>
        <description>Change from baseline in sPD-L1 could not be calculated as all post-baseline samples were below the lower limit of quantification (&lt;15.60 pg/mL).</description>
        <time_frame>Baseline (Cycle 1 Day 1 predose) and Day 1 of Cycles 2 to 13</time_frame>
        <population>Biomarker Evaluable Population included all participants who received at least 1 dose of study drug and had at least 1 non-missing biomarker assessment. No participants had quantifiable sPD-L1 measurements post-baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
            <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
          </group>
          <group group_id="O2">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O3">
            <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
          </group>
          <group group_id="O4">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O5">
            <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O6">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O7">
            <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O8">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O9">
            <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
            <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O10">
            <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
            <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O11">
            <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
          </group>
          <group group_id="O12">
            <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O13">
            <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
          </group>
          <group group_id="O14">
            <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
          </group>
          <group group_id="O15">
            <title>Part 2, Arm D FL: DUR 1500 mg</title>
            <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O16">
            <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
            <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O17">
            <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
            <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O18">
            <title>Part 2, Arm D MCL: DUR 1500 mg</title>
            <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
          <group group_id="O19">
            <title>Part 2 Arm D HL: DUR 1500 mg</title>
            <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Soluble Programmed Cell Death Ligand-1 (sPD-L1) Concentration</title>
          <description>Change from baseline in sPD-L1 could not be calculated as all post-baseline samples were below the lower limit of quantification (&lt;15.60 pg/mL).</description>
          <population>Biomarker Evaluable Population included all participants who received at least 1 dose of study drug and had at least 1 non-missing biomarker assessment. No participants had quantifiable sPD-L1 measurements post-baseline.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From first dose of any study drug to 90 days after last dose of durvalumab or 28 days after last dose of other study drugs, up to the data cut-off date of 6 March 2019. Maximum time on treatment was 55.4 weeks for DUR and 130 weeks for other study drugs. All-cause mortality includes all deaths through the data cut-off date; median (minimum, maximum) time on study was 16.7 (0.9, 32.9) months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg</title>
          <description>Participants received durvalumab (DUR) 1500 mg intravenous (IV) infusion on Day 1 of Cycles 1 through 13 (ie, 12 months) and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent non-Hodgkin's lymphoma (NHL) or for all cycles of treatment period until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL.</description>
        </group>
        <group group_id="E2">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 20 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 20 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
        </group>
        <group group_id="E3">
          <title>Part 1, Arm A: DUR 1500 mg + LEN 10 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab (DUR) 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and lenalidomide (LEN) 10 mg orally once daily on Days 1 to 21 of Cycles 1 through 13 for participants with indolent NHL or until disease progression, unacceptable toxicity, or discontinuation for any other reason in participants with aggressive NHL, and rituximab 375 mg/m² IV infusion on Days 2, 8, 15, 22 of Cycle 1 and on Day 1 of every 28-day cycle from Cycles 2 through 5.</description>
        </group>
        <group group_id="E4">
          <title>Part 1, Arm B: DUR 1500 mg + IBR 420 mg</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib orally 420 mg once daily until disease progression, unacceptable toxicity or discontinuation for any other reason</description>
        </group>
        <group group_id="E5">
          <title>Part 1, Arm B: DUR 1500 mg + IBR 560 mg</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib orally 560 mg once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="E6">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for participants with CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="E7">
          <title>Part 1, Arm C: DUR 1500 mg + BEN 70 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="E8">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="E9">
          <title>Part 1, Arm C: DUR 1500 mg + RIT 375 mg/m² + BEN 90 mg/m²</title>
          <description>Participants received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 90 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="E10">
          <title>Part 2, Arm B CLL/SLL: DUR 1500 mg + IBR 420 mg</title>
          <description>Participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 420 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="E11">
          <title>Part 2, Arm B MCL: DUR 1500 mg + IBR 560 mg</title>
          <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13 and ibrutinib 560 mg orally once daily until disease progression, unacceptable toxicity or discontinuation for any other reason.</description>
        </group>
        <group group_id="E12">
          <title>Part 2, Arm C FL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with follicular lymphoma (FL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="E13">
          <title>Part 2 Arm C DLBCL: DUR 1500 mg + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6.</description>
        </group>
        <group group_id="E14">
          <title>Part 2, Arm C CLL/SLL: DUR + RIT 375 mg/m² + BEN 70 mg/m²</title>
          <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13, bendamustine 70 mg/m² IV infusion on Days 1 and 2 of Cycles 1 through 6, and rituximab 375 mg/m² IV infusion on Day 2 of Cycles 1 through 6 (for CLL the rituximab dose was 375 mg/m² Cycle 1 first dose and 500 mg/m² for each subsequent dose).</description>
        </group>
        <group group_id="E15">
          <title>Part 2, Arm D FL: DUR 1500 mg</title>
          <description>Participants with follicular lymphoma received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="E16">
          <title>Part 2, Arm D DLBCL: DUR 1500 mg</title>
          <description>Participants with diffuse large B-cell lymphoma (DLBCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="E17">
          <title>Part 2, Arm D CLL/SLL: DUR 1500 mg</title>
          <description>Participants with CLL or SLL received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="E18">
          <title>Part 2, Arm D MCL: DUR 1500 mg</title>
          <description>Participants with mantle cell lymphoma (MCL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
        <group group_id="E19">
          <title>Part 2, Arm D hL: DUR 1500 mg</title>
          <description>Participants with Hodgkin lymphoma (HL) received durvalumab 1500 mg IV infusion on Day 1 of Cycles 1 through 13.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="9" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="8" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Aptyalism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Colon dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastrointestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Cytokine release syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pleural infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>General physical condition abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Organising pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Drug reaction with eosinophilia and systemic symptoms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Jugular vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Superior vena cava syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="5" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="5" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Bone marrow failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eosinophilia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Immune thrombocytopenic purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Increased tendency to bruise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pericardial disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Epidermolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Conjunctival oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eyelid disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Iritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Periorbital oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Retinopathy hypertensive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vitreous detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lip dry</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lip haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Oesophageal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Early satiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Face oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gravitational oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nodule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pneumatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="4" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Temperature intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hepatocellular injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypertransaminasaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ocular icterus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypogammaglobulinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Immunodeficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Enterocolitis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Herpes ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Herpes virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Human herpesvirus 6 infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lip infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Metapneumovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Oral fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rhinovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Stenotrophomonas sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Urinary tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Allergic transfusion reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eye contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Infusion related reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Transfusion reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Amylase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood lactate dehydrogenase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Immunoglobulins decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lymphocyte count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lymphocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Monocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Streptococcus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>White blood cell count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperlactacidaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tumour lysis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Joint noise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Muscle mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tumour flare</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cardiovascular somatic symptom disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Micturition urgency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Urinary tract pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Penile oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Laryngeal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nasal dryness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Nasal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pharyngeal erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rales</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Sinus pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Upper-airway cough syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dermatitis acneiform</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dermatitis exfoliative generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eczema asteatotic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Eczema nummular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hyperkeratosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Neurodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Onychoclasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Skin fissures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Axillary vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Embolism venous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Results from a center cannot be submitted for publication before results of multicenter study are published unless it is &gt; 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 additional days. Investigator must delete confidential information before submission and defer publication to permit patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Anne McClain</name_or_title>
      <organization>Celgene Corporation</organization>
      <phone>1-888-260-1599</phone>
      <email>clinicaltrialdisclosure@celgene.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

